Connor, Clark & Lunn Investment Management (CC&L)’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-18
Closed -$52K 768
2013
Q3
$52K Buy
18
+3
+20% +$8.67K ﹤0.01% 504
2013
Q2
$145K Buy
+15
New +$145K ﹤0.01% 490